| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 15 | 0.0002 |
| 1 | Proteasome Inhibitor [EPC] | 11 | 0.0001 |
| 2 | Platinum-based Drug [EPC] | 18 | 0.0001 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 10 | 0.0000 |
| 5 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 2 | 0.0000 |
| 8 | Corticosteroid [EPC] | 17 | 0.0000 |
| 9 | Catecholamine [EPC] | 1 | 0.0000 |
| 10 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 11 | Opioid Agonist [EPC] | 2 | 0.0000 |
| 12 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 13 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 14 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 15 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 | 0.0000 |
| 16 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 17 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |